Health Economics of Rotavirus Immunization in Vietnam: Potentials for Favorable Cost-Effectiveness in Developing Countries
This article, published in Vaccine, reports on a study designed to assess the cost-effectiveness of rotavirus immunization in Vietnam. It specifically focused on the use of RotaTeq® and assessing the affordability of implementing universal rotavirus immunization based on GAVI-subsidized vaccine price in the context of Vietnamese healthcare system for the next five years. The results determined that rotavirus vaccination in Vietnam would be a cost-effective health intervention. Vaccination only becomes affordable if the country receives GAVI's financial support due to the current high market vaccine price. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ. Health Economics of Rotavirus Immunization in Vietnam: Potentials for Favorable Cost-Effectiveness in Developing Countries. Vaccine. 2012;30(8):1521-1528.